+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ADVIKLA ADVIKLA
₹2.18 +0.1 (4.81%)
New 52W High today

16 Nov, 2026 4:01 PM (IST)

MPS Pharma live price: ₹2.18. It opened at ₹2 vs previous close ₹2; intraday high/low: ₹2/₹2. The 50 & 200 DMA stand at ₹2.10/₹2.30.

MPS Pharma Performance

  • Today's Low
  • ₹2
  • Today's High
  • ₹2
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹2
  • Open Price₹2
  • Previous Close₹2
  • Volume100
  • 50 DMA₹2.10
  • 100 DMA₹2.30
  • 200 DMA₹2.30

MPS Pharma Chart

Investment Returns

  • Over 1 Month + 4.81%
  • Over 3 Month + 9.55%
  • Over 6 Month + 26.01%
  • Over 1 Year + 18.48%

Smart Investing Starts Here Start SIP with MPS Pharma for Steady Growth!

Invest Now

MPS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -4.2
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 4
  • P/B Ratio
  • -24.6
  • Average True Range
  • 0
  • EPS
  • -0.5
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.1
  • RSI
  • 76.27
  • MFI
  • 100

Latest Stock News Updates

Advik Laboratories Ltd - 531686 - Announcement under Regulation 30 (LODR)-Newspaper Publication

newspaper publication

Advik Laboratories Ltd - 531686 - Outcome Of The Board Meeting And Submission Of Standalone Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2026 As Required U/R 33 Of The SEBI (LODR) Regulations, 2015

PFA Outcome of the Board Meeting and Submission of Standalone Un-audited Financial Results for the Quarter and Half Year ended 30th September , 2026

Advik Laboratories Ltd - 531686 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Standalone Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2026 As Required U/R 33 Of The SEBI (LODR) Regulations, 2015.

PFA Outcome of the Board Meeting and Submission of Standalone Un-audited Financial Results for the quarter and half year ended 30th September, 2026 as required u/r 33 of the SEBI (LODR) Regulations, 2015.

MPS Pharma Financials

MPS Pharma Technicals

EMA & SMA

Current Price
₹2.18
+ 0.1 (4.81%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹2.00
  • 50 Day
  • ₹2.10
  • 100 Day
  • ₹2.30
  • 200 Day
  • ₹2.30

Resistance and Support

2.19 Pivot Speed
  • R3 2.20
  • R2 2.20
  • R1 2.20
  • S1 2.20
  • S2 2.20
  • S3 2.20

MPS Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-13 Quarterly Results
2026-09-02 A.G.M.
2026-08-13 Quarterly Results
2026-05-28 Audited Results
2026-02-02 Quarterly Results

MPS Pharma Shareholding Pattern

63.53%
35.89%
0.58%

About MPS Pharma

MPS Pharmaa engaged in manufacturing, marketing, trading and export of Pharmaceutical Products. The Company has its own manufacturing facility at Sohna. View More
  • NSE Symbol
  • ADVIKLA
  • BSE Symbol
  • 531686
  • ISIN
  • INE537C01019

Similar Stocks to MPS Pharma

MPS Pharma FAQs

MPS Pharma share price is ₹2 As on 19 November, 2026 | 19:56

The Market Cap of MPS Pharma is ₹4.2 Cr As on 19 November, 2026 | 19:56

The P/E ratio of MPS Pharma is -4.2 As on 19 November, 2026 | 19:56

The PB ratio of MPS Pharma is -24.6 As on 19 November, 2026 | 19:56

The 52 week High & Low of MPS Pharma is ₹2.2/₹1.6 respectively As on 19 November, 2026 | 19:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23